The Role of M6A in Angiogenesis and Vascular Diseases

Overview

Journal iScience

Publisher Cell Press

Date 2024 Jul 26

PMID 39055919

Authors

Ke Chen

Wen-Dong Li

Xiao-Qiang Li

Affiliations

Soon will be listed here.

Abstract

Angiogenesis, whether physiological or pathological, plays a pivotal role in various physiological and disease conditions. This intricate process relies on a complex and meticulously orchestrated signal transduction network that connects endothelial cells, their associated parietal cells (VSMCs and pericytes), and various other cell types, including immune cells. Given the significance of m6A and its connection to angiogenesis and vascular disease, researchers must adopt a comprehensive and ongoing approach to their investigations. This study aims to ascertain whether a common key mechanism of m6A exists in angiogenesis and vascular diseases and to elucidate the potential application of m6A in treating vascular diseases.

References

Zhang G, Wang T, Huang Z, Chen Y, Sun L, Xia X . METTL3 dual regulation of the stability of LINC00662 and VEGFA RNAs promotes colorectal cancer angiogenesis. Discov Oncol. 2022; 13(1):89. PMC: 9482670. DOI: 10.1007/s12672-022-00557-3. View

Liu X, He H, Zhang F, Hu X, Bi F, Li K . m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling. Cell Death Dis. 2022; 13(5):483. PMC: 9122982. DOI: 10.1038/s41419-022-04950-2. View

Qi Y, Yao R, Zhang W, Cui Q . KAT1 triggers YTHDF2-mediated ITGB1 mRNA instability to alleviate the progression of diabetic retinopathy. Pharmacol Res. 2021; 170:105713. DOI: 10.1016/j.phrs.2021.105713. View

Wang L, Hui H, Agrawal K, Kang Y, Li N, Tang R . m A RNA methyltransferases METTL3/14 regulate immune responses to anti-PD-1 therapy. EMBO J. 2020; 39(20):e104514. PMC: 7560214. DOI: 10.15252/embj.2020104514. View

Liu T, Zhou H, Lu H, Luo C, Wang Q, Peng Y . MiR-4729 regulates TIE1 mRNA m6A modification and angiogenesis in hemorrhoids by targeting METTL14. Ann Transl Med. 2021; 9(3):232. PMC: 7940907. DOI: 10.21037/atm-20-3399. View

Fu C, Feng L, Zhang J, Sun D . Bioinformatic analyses of the role of m6A RNA methylation regulators in abdominal aortic aneurysm. Ann Transl Med. 2022; 10(10):547. PMC: 9201186. DOI: 10.21037/atm-22-1891. View

Wang L, Xue Y, Huo R, Yan Z, Xu H, Li H . N6-methyladenosine methyltransferase METTL3 affects the phenotype of cerebral arteriovenous malformation via modulating Notch signaling pathway. J Biomed Sci. 2020; 27(1):62. PMC: 7210675. DOI: 10.1186/s12929-020-00655-w. View

Hu L, Yu Y, Shen Y, Huang H, Lin D, Wang K . Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages. Redox Biol. 2023; 61:102638. PMC: 9975317. DOI: 10.1016/j.redox.2023.102638. View

Fang H, Sun Q, Zhou J, Zhang H, Song Q, Zhang H . mA methylation reader IGF2BP2 activates endothelial cells to promote angiogenesis and metastasis of lung adenocarcinoma. Mol Cancer. 2023; 22(1):99. PMC: 10288689. DOI: 10.1186/s12943-023-01791-1. View

10.

Wang L, Xue Y, Li H, Huo R, Yan Z, Wang J . Wilms' tumour 1-associating protein inhibits endothelial cell angiogenesis by m6A-dependent epigenetic silencing of desmoplakin in brain arteriovenous malformation. J Cell Mol Med. 2020; 24(9):4981-4991. PMC: 7205785. DOI: 10.1111/jcmm.15101. View

11.

Song P, Tayier S, Cai Z, Jia G . RNA methylation in mammalian development and cancer. Cell Biol Toxicol. 2021; 37(6):811-831. PMC: 8599391. DOI: 10.1007/s10565-021-09627-8. View

12.

Parial R, Li H, Li J, Archacki S, Yang Z, Wang I . Role of epigenetic m A RNA methylation in vascular development: mettl3 regulates vascular development through PHLPP2/mTOR-AKT signaling. FASEB J. 2021; 35(5):e21465. DOI: 10.1096/fj.202000516RR. View

13.

Paramasivam A, Priyadharsini J, Raghunandhakumar S . N6-adenosine methylation (m6A): a promising new molecular target in hypertension and cardiovascular diseases. Hypertens Res. 2019; 43(2):153-154. DOI: 10.1038/s41440-019-0338-z. View

14.

Tong J, Flavell R, Li H . RNA mA modification and its function in diseases. Front Med. 2018; 12(4):481-489. DOI: 10.1007/s11684-018-0654-8. View

15.

Shan K, Zhou R, Xiang J, Sun Y, Liu C, Lv M . FTO regulates ocular angiogenesis via mA-YTHDF2-dependent mechanism. Exp Eye Res. 2020; 197:108107. DOI: 10.1016/j.exer.2020.108107. View

16.

Wu Z, Lin Y, Wei N . N6-methyladenosine-modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma. Cancer Sci. 2022; 114(1):129-141. PMC: 9807531. DOI: 10.1111/cas.15578. View

17.

Qu X, Zhang L, Li S, Li T, Zhao X, Wang N . mA-Related Angiogenic Genes to Construct Prognostic Signature, Reveal Immune and Oxidative Stress Landscape, and Screen Drugs in Hepatocellular Carcinoma. Oxid Med Cell Longev. 2022; 2022:8301888. PMC: 9554665. DOI: 10.1155/2022/8301888. View

18.

Song H, Feng X, Zhang H, Luo Y, Huang J, Lin M . METTL3 and ALKBH5 oppositely regulate mA modification of mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. Autophagy. 2019; 15(8):1419-1437. PMC: 6613905. DOI: 10.1080/15548627.2019.1586246. View

19.

Yao M, Jiang Q, Ma Y, Liu C, Zhu C, Sun Y . Role of METTL3-Dependent N-Methyladenosine mRNA Modification in the Promotion of Angiogenesis. Mol Ther. 2020; 28(10):2191-2202. PMC: 7545007. DOI: 10.1016/j.ymthe.2020.07.022. View

20.

Li Z, Xu Q, Huangfu N, Chen X, Zhu J . Mettl3 promotes oxLDL-mediated inflammation through activating STAT1 signaling. J Clin Lab Anal. 2021; 36(1):e24019. PMC: 8761454. DOI: 10.1002/jcla.24019. View